These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32008423)
21. Safe harbors in Europe: an update on the research and Bolar exemptions to patent infringement. Kupecz A; Roox K; Dekoninck C; Schertenleib D; Stief M; Sanna F; Orsingher M; Miralles S; Molina E; Crosse T; Gilbert M; James W Nat Biotechnol; 2015 Jul; 33(7):710-5. PubMed ID: 26154008 [No Abstract] [Full Text] [Related]
22. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
23. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
24. Trends in the human embryonic stem cell patent field. Karlsson U; Hyllner J; Runeberg K Recent Pat Nanotechnol; 2007; 1(3):233-7. PubMed ID: 19076035 [TBL] [Abstract][Full Text] [Related]
25. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
27. Companies balk at California's patent rules for stem cell research. Keim B Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112 [No Abstract] [Full Text] [Related]
28. Gene patenting and medical research: a view from a pharmaceutical company. Stott M; Valentine J Nat Rev Drug Discov; 2004 Apr; 3(4):364-8. PubMed ID: 15060532 [No Abstract] [Full Text] [Related]
34. Reforming the Orphan Drug Act for the 21st Century. Sarpatwari A; Kesselheim AS N Engl J Med; 2019 Jul; 381(2):106-108. PubMed ID: 31291512 [No Abstract] [Full Text] [Related]
35. Anchoring gene patent eligibility to its constitutional mooring. Chahine KG Nat Biotechnol; 2010 Dec; 28(12):1251-5. PubMed ID: 21139606 [No Abstract] [Full Text] [Related]
36. Biotechnology--a challenge to the patent system. Farnley S; Morey-Nase P; Sternfeld D Curr Opin Biotechnol; 2004 Jun; 15(3):254-7. PubMed ID: 15193336 [TBL] [Abstract][Full Text] [Related]
37. "Obvious to try": a proper patentability standard in the pharmaceutical arts? Trask AV Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581 [No Abstract] [Full Text] [Related]
38. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies. Bouchard RA Health Law J; 2007; 15():247-94. PubMed ID: 19702185 [No Abstract] [Full Text] [Related]
39. The impact of effective patents on future innovations in nanomedicine. Bosetti R; Vereeck L Pharm Pat Anal; 2012 Mar; 1(1):37-43. PubMed ID: 24236712 [TBL] [Abstract][Full Text] [Related]